ArticlebioRxiv : the preprint server for biology2024
Bone marrow microenvironment signatures associate with patient survival after guadecitabine and atezolizumab therapy in HMA-resistant MDS.
H Josh Jang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.